HER2 Breast Cancer Tweetorial 2: Examining the Implications of HER2-low

This 30-minute, CME/CMLE-accredited, Tweetorial was designed to help pathologists, laboratory professionals, and other members of the cancer care team gain an understanding of the clinical implications around HER2-low breast cancer and HER2 testing guidelines. This Tweetorial will cover the following topics: HER2-low breast cancer, HER2-low classification, the clinical implications of HER2-low for the cancer care team, and tools and resources for pathologists.

Target Audience

This activity has been designed to meet the educational needs of pathologists, laboratory professionals, and other members of the cancer care team.

Activity Agenda

• Introductions
• HER2-low breast cancer
• Clinical implications around HER2-low
• Wrap up

The activity offers 0.5 CME/CMLE credit.

Faculty Disclosures
Dr. Kim has no relevant financial relationships to disclose

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

The ASCP designates this enduring internet activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ASCP designates this enduring internet activity for a maximum of 0.5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.